Ledger.Open graph →
SEC Form D · filed May 22, 2023

Eledon Pharmaceuticals, Inc

Offering
—
Sold
$35.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
IRVINE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

John Mcbride · Irvine, CADirectorGary Lyons · Irvine, CADirectorKeith Katkin · Irvine, CADirectorFrederick Brumder · Bend, ORDirectorPaolo Crozzoli · Luxembourg, LuxembourgDirectorJohn Lykouretzos · NEW YORK, NYDirectorJan Hillson · Irvine, CADirectorBryan Smith · Richmond, TXExecWalter Ogier · Boston, MADirectorSteven Perrin · CAMBRIDGE, MAExec · DirectorPaul Little · Pine Ridge, SDExecJune Lee · Irvine, CADirectorDavid-Alexandre Gros · Rancho Santa Fe, CAExec · DirectorKathleen L. Herrin · Chicago, ILDirectorAlphonse L. Iudicello · Chicago, ILDirector[No Name] Boyd Watterson GSA GP, LLC · Cleveland, OHDirectorJan Hillson · Irvine, CADirectorBryan Smith · Kokomo, INExecWalter Ogier · Cambridge, MADirectorSteven Perrin · CAMBRIDGE, MAExec · DirectorPaul Little · Irvine, CAExecJune Lee · Irvine, CADirectorDavid-Alexandre Gros · Rancho Santa Fe, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗